Singapore markets closed

Gritstone bio, Inc. (GRTS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7979-0.0244 (-2.97%)
As of 02:43PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 89.28M
Enterprise value 146.26M
Trailing P/E 0.60
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)114.34
Price/book (mrq)6.39
Enterprise value/revenue 174.53
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3-52.05%
S&P500 52-week change 325.26%
52-week high 33.3300
52-week low 30.6700
50-day moving average 31.2784
200-day moving average 31.7954

Share statistics

Avg vol (3-month) 33.03M
Avg vol (10-day) 32.16M
Shares outstanding 5108.57M
Implied shares outstanding 6111.18M
Float 8100.14M
% held by insiders 12.38%
% held by institutions 143.80%
Shares short (30 Apr 2024) 415.11M
Short ratio (30 Apr 2024) 43.19
Short % of float (30 Apr 2024) 414.44%
Short % of shares outstanding (30 Apr 2024) 414.11%
Shares short (prior month 28 Mar 2024) 49.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,284.79%

Management effectiveness

Return on assets (ttm)-52.07%
Return on equity (ttm)-187.15%

Income statement

Revenue (ttm)15.64M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)-28.70%
Gross profit (ttm)N/A
EBITDA -137.07M
Net income avi to common (ttm)-144.89M
Diluted EPS (ttm)-1.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.3M
Total cash per share (mrq)0.43
Total debt (mrq)103.28M
Total debt/equity (mrq)739.63%
Current ratio (mrq)2.00
Book value per share (mrq)0.14

Cash flow statement

Operating cash flow (ttm)-115.12M
Levered free cash flow (ttm)-72.95M